Adam Freund
Founder & Chief Executive Officer Arda Therapeutics
Seminars
Wednesday 28th January 2026
Advancing Pathogenic Cell Targeting: Selecting Senescent & Other Pathogenic Cell States with Precision to Maximize Therapeutic Benefit
12:00 pm
- Mapping pathogenic cell states through integration of multi-modal single-cell and spatial data from thousands of human donors
- Uncovering precision surface markers that enable selective depletion of the harmful cell populations
- Restoring tissue balance by targeting chronic inflammation at its cellular source
